The Philippines in 2016 was the first nation to use Dengvaxia in a mass immunisation programme, but Sanofi disclosed a year later that it could worsen symptoms for people not previously infected by the dengue virus.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: